Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF versus TDF for prevention of mother-to-child transmission of hepatitis B in pregnant women with high viremia
ChiCTR1900028207Phase 4Recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-Sen University
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir alafenamide and tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by The Seventh Affiliated Hospital, Sun Yat-Sen University. Primary endpoints: Serum markers for hepatitis B, HBV DNA level and 4 more. Started Sep 2019; status: recruiting.
02
Drugs
tenofovir alafenamidetenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR1900028207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028207.